In an implantable devices supply chain special interest group meeting hosted by Louisville, Colo.-based GHX, suppliers and providers saw different possible results that could come from formally implementing the U.S. Food and Drug Administration's final rule on Unique Device Identifiers.
Supply Chain
JCB Laboratories, a sterile compounding pharmacy in Wichita, Kan., has installed a continuous cleanroom monitoring system from Fremont, Calif.-based Lighthouse Worldwide Solutions to help catch contamination errors before they become problems.
Woonsocket, R.I.-based CVS Caremark and Dublin, Ohio-based Cardinal Health have signed a 50/50 joint venture agreement, forming the largest generic drug sourcing operation in the U.S., according to a Reuters report.
The world's smallest, minimally invasive pacemaker, the Micra Transcatheter Pacing System produced by Minneapolis-based Medtronic, was implanted in a patient in Linz, Austria as part of the global clinical trial for the device, according to a Market Watch report.
The market for medical bionic implants, or artificial organs, is expected to reach $17.8 billion by 2017, according to a MarketsandMarkets report.
Irvine, Calif.-based Reverse Medical Corporation has received 501(k) clearance from the U.S. Food and Drug Administration to market its MVP-5 Micro Vascular Plug system, according to a news release.
The wearable medical device market is expected to reach $5.8 billion by 2019, growing at a compound annual growth rate of 16.4 percent, according to a Transparency Market Research report.
Here are five statistics about the medical device market compiled from previous posts on Becker's Hospital Review, starting with the most recent.
The Philadelphia Pediatric Device Consortium has received a $1.5 million, five-year grant from the U.S. Food and Drug Administration for addressing the shortage of medical devices designed for children.
The global Medical Automation Market is expected to reach $66.92 billion by 2018, according to a report released by MarketsandMarkets.